journal article·2015-06

Permeation of platinum and rhodium nanoparticles through intact and damaged human skin

Marcella Mauro, Matteo Crosera, Carlotta Bianco, Gianpiero Adami, Tiziano Montini, Paolo Fornasiero, Morana Jaganjac, Massimo Bovenzi, Francesca Larese Filon

Journal of Nanoparticle Research· Volume 17· Issue 6
Publisher page

Abstract

The aim of the study was to evaluate percutaneous penetration of platinum and rhodium nanoparticles (PtNPs: 5.8 ± 0.9 nm, RhNPs: 5.3 ± 1.9 nm) through human skin. Salts compounds of these metals are sensitizers and some also carcinogenic agents. In vitro permeation experiments were performed using Franz diffusion cells with intact and damaged skin. PtNPs and RhNPs, stabilized with polyvinylpyrrolidone, were synthesized by reduction of Na2PtCl6 and RhCl3·3H2O respectively. Suspensions with a concentration of 2.0 g/L of PtNPs and RhNPs were dispersed separately in synthetic sweat at pH 4.5 and applied as donor phases to the outer surface of the skin for 24 h. Measurements of the content of the metals in the receiving solution and in the skin were performed subsequently. Rhodium skin permeation was demonstrated through damaged skin, with a permeation flux of 0.04 ± 0.04 μg cm−2 h−1 and a lag time of 7.9 ± 1.1 h, while no traces of platinum were found in receiving solutions. Platinum and rhodium skin- analysis showed significantly higher concentrations of the metals in damaged skin. Rh and Pt applied as NPs can penetrate the skin barrier and Rh can be found in receiving solutions. These experiments pointed out the need for skin contamination prevention, since even a minor injury to the skin barrier can significantly increase penetration.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Contact Dermatitis and Allergies · Heavy Metal Exposure and Toxicity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Barbante C, Veysseyre A, Ferrari C, van de Velde K, Morel C, Capodaglio G, Cescon P, Scarponi G, Boutron C (2001) Greenland snow evidence of large scale atmospheric contamination for platinum, palladium and rhodium. Environ Sci Technol 35:835–83910.1021/es000146y ↗
2. Baroli B (2010) Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci 99:21–5010.1002/jps.21817 ↗
3. Birchall J, Coulman S, Anstey A, Gateley C, Sweetland H, Gershonowitz A, Neville L, Levin G (2006) Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. Int J Pharm 312(1–2):15–2310.1016/j.ijpharm.2005.12.036 ↗
4. Blosi M, Albonetti S, Dondi M, Martelli C, Baldi G (2011) Microwave-assisted polyol synthesis of Cu nanoparticles. J Nanopart Res 13:127–13810.1007/s11051-010-0010-7 ↗
5. Blosi M, Albonetti S, Ortelli S, Costa AL, Ortolani L, Dondi M (2014) Green and easily scalable microwave synthesis of noble metal nanosols (Au, Ag, Cu, Pd) usable as catalysts. New J Chem 38:1401–140910.1039/C3NJ00894K ↗
6. Bocca B, Caimi S, Smichowski P, Gómez D, Caroli S (2006) Monitoring Pt and Rh in urban aerosols from Buenos Aires, Argentina. Sci Total Environ 358(1–3):255–26410.1016/j.scitotenv.2005.04.010 ↗
7. Bronaugh RL, Steward RF (1985) Methods for in vitro percutaneous absorption studies V: permeation through damaged skin. J Pharm Sci 74:1062–106610.1002/jps.2600741008 ↗
8. Brubaker PE, Moran JP, Bridbord K, Hueter FG (1975) Noble metals: a toxicological appraisal of potential new environmental contaminants. Environ Health Perspect 10:39–5610.1289/ehp.751039 ↗
9. Bünger J, Stork J, Stalder K (1996) Cyto and genotoxic effects of coordination complexes of platinum, palladium and rhodium in vitro. Int Arch Occup Environ Health 69(1):33–3810.1007/BF02630736 ↗
10. Carneiro ML, Nunes ES, Peixoto RC, Oliveira RG, Lourenço LH, da Silva IC, Simioni AR, Tedesco AC, de Souza AR, Lacava ZG, Báo SN (2011) Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy. J Nanobiotechnol. doi: 10.1186/1477-3155-9-11
11. Colombo C, Monhemius AJ, Plant JA (2008a) The estimation of the bioavailabilities of platinum, palladium and rhodium in vehicle exhaust catalysts and road dusts using a physiologically based extraction test. Sci Total Environ 389(1):46–5110.1016/j.scitotenv.2007.08.022 ↗
12. Colombo C, Monhemius AJ, Plant JA (2008b) Platinum, palladium and rhodium release from vehicle exhaust catalysts and road dust exposed to simulated lung fluids. Ecotoxicol Environ Saf 71(3):722–73010.1016/j.ecoenv.2007.11.011 ↗
13. Cristaudo A, Sera F, Severino V, De Rocco M, Di Lella E, Picardo M (2005) Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy 60(2):159–16410.1111/j.1398-9995.2004.00521.x ↗
14. Davies DJ, Ward RJ, Heylings JR (2004) Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol In Vitro 18(3):351–35810.1016/j.tiv.2003.10.004 ↗
15. EDETOX Evaluations and predictions of dermal absorption of toxic chemicals (2001–2004) QLK4-CT-2000-00196. www.edetox.ncl.ac.uk
16. Fasano WJ, Manning LA, Green JW (2002) Rapid assessment of rat and human epidermal membranes for in vitro dermal regulatory testing: correlation of electrical resistance with tritiated water permeability. Toxicol In Vitro 16(6):731–74010.1016/S0887-2333(02)00084-X ↗
17. Forte G, Petrucci F, Bocca B (2008) Metal allergens of growing significance: epidemiology, immunotoxicology, strategies for testing and prevention. Inflamm Allergy Drug Targets 7(3):145–16210.2174/187152808785748146 ↗
18. Franken A, Eloff FC, Du Plessis J, Badenhorst J, Jordaan A, Du Plessis L (2014) In vitro permeation of platinum and rhodium through caucasian skin. Toxicol In Vitro 28(8):1396–140110.1016/j.tiv.2014.07.007 ↗
19. Franz TJ (1975) Percutaneous absorption. On the relevance of in vitro data. J Investig Dermatol 93:633–640
20. Fuchs WA, Rose AW (1974) Geochemical behavior of platinum and palladium in the weathering cycle in the stillwater complex. Montana Econ Geol 69:332–34610.2113/gsecongeo.69.3.332 ↗
21. Gebel T, Lantzsch H, Plessow K, Dunkelberg H (1997) Genotoxicity of platinum and palladium compounds in human and bacterial cells. Mutat Res 389(2–3):183–19010.1016/S1383-5718(96)00145-3 ↗
22. Goossens A, Cattaert N, Nemery B, Boey L, De Graef E (2011) Occupational contact dermatitis caused by rhodium solutions. Contact Dermat 64(3):158–16110.1111/j.1600-0536.2010.01808.x ↗
23. Health and Safety Executive (1990) Occupational exposure limits. Guidance note EH 40910. London: Her Majestry’s Stationary Office
24. Hunter D, Milton R, Perry KMA (1945) Asthma caused by the complex salts of platinum. Br J Ind Med 2(2):92–98
25. Iavicoli I, Cufino V, Corbi M, Goracci M, Caredda E, Cittadini A, Bergamaschi A, Sgambato A (2012) Rhodium and iridium salts inhibit proliferation and induce DNA damage in rat fibroblasts in vitro. Toxicol In Vitro 26(6):963–96910.1016/j.tiv.2012.03.014 ↗
26. Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y (2007) Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radical Res 41(6):615–62610.1080/10715760601169679 ↗
27. Konieczny P, Goralczyk AG, Szmyd R, Skalniak L, Koziel J, Larese FF, Crosera M, Cierniak A, Zuba-Surma EK, Borowczyk J, Laczna E, Drukala J, Pyza E, Semik D, Woznicka O, Klein A, Jura J (2013) Effects triggered by platinum nanoparticles on primary keratinocytes. Int J Nanomed 8:3963–3975
28. Larese FF, D’Agostin F, Crosera M, Adami G, Bovenzi M, Maina G (2008) In vitro percutaneous absorption of chromium powder and the effect of skin cleanser. Toxicol In Vitro 22(6):1562–156710.1016/j.tiv.2008.06.006 ↗
29. Larese FF, D’Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, Maina G (2009a) Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 255(1–2):33–3710.1016/j.tox.2008.09.025 ↗
30. Larese FF, D’Agostin F, Crosera M, Adami G, Bovenzi M, Maina G (2009b) In vitro absorption of metal powders through intact and damaged skin. Toxicol In Vitro 23(4):574–57910.1016/j.tiv.2009.01.015 ↗
31. Larese FF, Crosera M, Adami G, Bovenzi M, Rossi F, Maina G (2011) Human skin penetration of gold nanoparticles through intact and damaged skin. Nanotoxicology 5(4):493–50110.3109/17435390.2010.551428 ↗
32. Larese FF, Crosera M, Timeus E, Adami G, Bovenzi M, Ponti J, Maina G (2013) Human skin penetration of cobalt nanoparticles through intact and damaged skin. Toxicol In Vitro 27(1):121–12710.1016/j.tiv.2012.09.007 ↗
33. Linett PJ, Hughes EG (1999) 20 years of medical surveillance on exposure to allergenic and non allergenic platinum compounds: the importance of chemical speciation. Occup Environ Med 56(3):191–19610.1136/oem.56.3.191 ↗
34. Merget R (2000) Occupational platinum salt allergy. Diagnosis, prognosis, prevention and therapy. In: Zereini F, Alt F (eds) Anthropogenic platinum-group element emissions. Their impact on man and environment. Springer-Verlag, Berlin, p 32
35. Merget R, Rosner G (2001) Evaluation of the health risk of platinum group metals emitted from automotive catalytic converters. Sci Total Environ 270(1–3):165–17310.1016/S0048-9697(00)00788-9 ↗
36. Merget R, Sander I, van Kampen V, Raulf-Heimsoth M, Ulmer HM, Kulzer R, Bruening T (2010) Occupational immediate-type asthma and rhinitis due to rhodium salts. Am J Ind Med 53(1):42–4610.1002/ajim.20786 ↗
37. Moldovan M, Palacios MA, Gòmez MM, Morrison G, Rauch S, McLeod C, Ma R, Caroli S, Alimonti A, Petrucci F, Bocca B, Schramel P, Zischka M, Pettersson C, Wass U, Luna M, Saenz JC, Santamaría J (2002) Environmental risk of particulate and soluble platinum group elements released from gasoline and diesel engine catalytic converters. Sci Total Environ 296(1–3):199–20810.1016/S0048-9697(02)00087-6 ↗
38. Murdoch RD, Pepys J (1987) Platinum group metal sensitivity: reactivity to platinum group metal salts in platinum halide salt-sensitive workers. Ann Allergy 59(6):464–469
39. Nakayama H, Ichikawa T (1997) Occupational contact urticaria syndrome due to rhodium and platinum. In: Amin S, Maibach HI, Lahti S (eds) Contact urticaria syndrome. CRC Press, New York, pp 233–240
40. Niezborala M, Garnier R (1996) Allergy to complex platinum salts: a historical prospective cohort study. Occup Environ Med 53(4):252–25710.1136/oem.53.4.252 ↗
41. Onizawa S, Aoshiba K, Kajita M, Miyamoto Y, Nagai A (2009) Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke. Pulm Pharmacol Ther 22(4):340–34910.1016/j.pupt.2008.12.015 ↗
42. Orbaek P (1982) Allergy to the complex salts of platinum, A review of the literature and three case reports. Scand J Work Environ Health 8(2):141–14510.5271/sjweh.2488 ↗
43. Peng Choo H, Yong Liew K, Liu H (2002) Factors affecting the size of polymer stabilized Pd nanoparticles. J Mater Chem 12:934–93710.1039/b108260b ↗
44. Rancan F, Gao Q, Graf C, Troppens S, Hadam S, Vogt A (2012) Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization and colloidal stability. ACS Nano 8:6829–684210.1021/nn301622h ↗
45. Ravindra K, Bencs L, Van Grieken R (2004) Platinum group elements in the environment and their health risk. Sci Total Environ 318(1–3):1–4310.1016/S0048-9697(03)00372-3 ↗
46. Roshchin AV, Veselov VG, Panova AI (1984) lndustrial toxicology of metals of the platinum group. J Hyg Epidemiol Microbiol Immunol 28:17–24
47. Santucci B, Valenzano C, de Rocco M, Cristaudo A (2000) Platinum in the environment: frequency of reactions to platinum-group elements in patients with dermatitis and urticaria. Contact Dermat 43(6):333–33810.1034/j.1600-0536.2000.043006333.x ↗
48. Schierl R (2000) Environmental monitoring of platinum in air and urine. Microchem J 67:245–24810.1016/S0026-265X(00)00068-0 ↗
49. Taubler J (1977) Allergic response to platinum and palladium complexes. Determination of no-effect level. US Environmental Protection Agency, North Carolina, EPA-600/1-77-039,NTIS Accession Number PB 271 659, p 81
50. WHO (1991) Environmental Health Criteria 125—Platinum. International Programme on Chemical Safety, Geneva
51. Yoshihisa Y, Honda A, Zhao QL, Makino T, Abe R, Matsui K, Shimizu H, Miyamoto Y, Kondo T, Shimizu T (2010) Protective effects of platinum nanoparticles against UV-light induced epidermal inflammation. Exp Dermatol 19(11):1000–100610.1111/j.1600-0625.2010.01128.x ↗
52. Zereini F, Skerstrupp B, Alt F, Helmers E, Urban H (1997) Geochemical behavior of platinum group elements (PGE) in particulate emissions by automobile exhaust catalysts: experimental results and environmental investigations. Sci Total Environ 206:137–14610.1016/S0048-9697(97)00219-2 ↗
53. Zhang W, Gao J, Zhu Q, Zhang M, Ding X, Wang X, Hou X, Fan W, Ding B, Wu X, Wang X, Gao S (2010) Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm 402:205–21210.1016/j.ijpharm.2010.09.037 ↗